Skip to main content

Advertisement

Table 5 Days in hospital for acute myeloid leukemia (AML) patients responding to treatment with valproic acid, all-trans retinoic acid (ATRA) and low-dose cytarabine

From: The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia

Patient Overall survival (days) Days in hospital relative to the total number of days:
From start of therapy to death For the last 28 days before death
CR1 296 59/ 296 0
CR2 383 42/ 383 8
SD1 102 18/ 102 14
SD2 419 20/ 419 6
SD3 171 54/ 171 4
SD4 151 93/ 151 23
SD5 239 80/ 239 18
SD6 147 35/ 147 2
SD7 132 41/ 132 4
SD8 > 574 12/ > 574 Still alive and living at home
SD9 > 141 12/ > 141 Still alive and living at home